Sign in to follow this  
Followers 0
Joelf

Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction (SVF) in the fingers of patients with systemic sclerosis.

1 post in this topic

Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction (SVF) in the fingers of patients with systemic sclerosis: an open-label phase I trial.

 

This study outlines the safety of the autologous SVF cells injection in the hands of patients with SSc and a significant improvement in hand disability and pain, Raynaud's phenomenon, finger oedema and quality of life was observed. PubMed, Ann rheumatologist Dis, 2014 Aug 11. (Also see: Vascular Involvement)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde

ISN Assistant Webmaster

SD World Webmaster

ISN Sclero Forums Manager

ISN News Manager

ISN Hotline Support Specialist

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0